Company | Sempra Energy |
Ticker | SRE |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 6, 2026 |
Prepared Date | August 5, 2026 |
Sector / Sub-sector | Utilities — Diversified (Electric & Gas) |
Key Takeaway: Setup is modestly constructive — consensus adjusted EPS of ~$1.06 is a low bar given Q1 came in at $1.51 and management affirmed full-year guidance, but the single biggest swing factor is whether Sempra can quantify the incremental ~$9B capital opportunity and provide a concrete update on the SIP/KKR transaction close, both of which management flagged for the Q2 call.
Heading into the Q2 2026 print, the bar for Sempra looks manageable: consensus adjusted EPS of ~$1.06 is well below Q1’s $1.51 and reflects typical seasonal softness, while the full-year 2026 guidance range of $4.80–$5.30 (midpoint $5.05) remains intact and affirmed. Management’s posture on the Q1 call was notably assertive — the Oncor rate case received final PUC approval with a higher authorized ROE of 9.75% and equity layer of 43.5%, and the positive financial impact was explicitly flagged as being “primarily recognized in Q2,” creating a visible earnings tailwind that the market may not have fully priced. Estimate revisions have been essentially flat since the Q1 print (FY2026 consensus moved from ~$5.17 to ~$5.14), suggesting the street is waiting for the Q2 call to update models on the incremental capital plan and SIP close timing rather than pre-positioning. The stock has underperformed XLU by roughly 3 percentage points since the Q1 print (SRE −5.4% vs. XLU −2.2%), implying the market has not priced in a beat, which creates an asymmetric setup if management delivers the promised capital update. The key wildcard is the SIP/KKR transaction close: management guided Q2 or Q3 2026, and a Q2 close would trigger immediate balance sheet improvement, eliminate equity needs through 2027, and catalyze rating agency threshold upgrades — a combination that could re-rate the stock meaningfully.
Key Takeaway: Consensus adjusted EPS of ~$1.06 is a low bar relative to Q1’s $1.51 and the full-year guidance midpoint of $5.05; the bigger swing factor is whether Oncor’s Q2 rate case benefit (flagged by management as “primarily Q2”) shows up in the print and whether management delivers the promised incremental capital update.
KPI | Last Quarter Actual (Q1 2026) | Prior Year Period (Q2 2025 Actual) | Consensus Estimate (Q2 2026) | YoY Change | Guidance | Consensus vs. Guidance (% delta) |
Adjusted EPS (Diluted Operating) | $1.51 | $0.89 | $1.06 | +19.1% YoY | FY2026: $4.80–$5.30 (mgmt affirmed; no Q-level guidance) | N/A (no Q-level guidance) |
Total Revenues | $3.655B | $3.000B | $3.186B | +6.2% YoY | No specific revenue guidance provided | N/A |
Total CapEx | $1.844B | $2.790B | $2.392B | −14.3% YoY | FY2026: ~$13B total T&D investment (mgmt target) | N/A (FY basis only) |
Oncor CapEx (Texas Utilities) | $0.876B | $0.485B | $2.028B | +80.0% YoY (FY consensus) | FY2026: $6.0B (VA consensus); $65B 5-yr base plan | N/A (FY basis only) |
FFO / Total Debt (%) | 15.5% (Q4 2025 actual) | 13.8% (Q2 2025 actual) | 14.2% (Q2 2026 consensus) | +0.4 pp YoY | No specific guidance; SIP close expected to improve credit metrics | N/A |
Sources: Visible Alpha Consensus and Actuals Data (EPS - Diluted - Operating, Total revenues, Total capital expenditure, Capital expenditure - Texas Utilities/Oncor, FFO/Total debt); Sempra Q1 2026 Earnings Call (May 7, 2026) for guidance references.
Top 2 KPIs: (1) Adjusted EPS (Diluted Operating) | (2) Total Revenues
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. EPS | $1.51 | $1.52 | −0.7% | In-Line |
Q1 2026 | Revenue | $3.655B | $4.048B | −9.7% | Miss |
Q4 2025 | Adj. EPS | $1.28 | $1.19 | +7.5% | Beat |
Q4 2025 | Revenue | $3.749B | $4.535B | −17.3% | Miss |
Q3 2025 | Adj. EPS | $1.11 | $0.91 | +21.9% | Beat |
Q3 2025 | Revenue | $3.151B | $3.199B | −1.5% | In-Line |
Q2 2025 | Adj. EPS | $0.89 | $0.85 | +5.0% | Beat |
Q2 2025 | Revenue | $3.000B | $3.325B | −9.8% | Miss |
Q1 2025 | Adj. EPS | $1.44 | $1.30 | +10.8% | Beat |
Q1 2025 | Revenue | $3.802B | $3.944B | −3.6% | In-Line / Miss |
Q4 2024 | Adj. EPS | $1.53 | $1.58 | −3.2% | In-Line / Miss |
Q4 2024 | Revenue | $3.758B | $4.935B | −23.8% | Miss |
Q3 2024 | Adj. EPS | $0.89 | $1.08 | −17.6% | Miss |
Q3 2024 | Revenue | $2.776B | $3.557B | −22.0% | Miss |
Q2 2024 | Adj. EPS | $0.89 | $0.93 | −4.3% | In-Line / Miss |
Q2 2024 | Revenue | $3.011B | $3.397B | −11.4% | Miss |
Pattern: SRE consistently beats on adjusted EPS (4 of last 5 quarters with a positive surprise) but persistently misses on reported revenue — a structural pattern driven by pass-through cost volatility and the reclassification of Sempra Infrastructure assets to held-for-sale. Investors and analysts have largely learned to look through revenue misses and focus on operating EPS and segment earnings.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance has been unchanged since the Q1 2026 call — FY2026 adjusted EPS of $4.80–$5.30 and FY2027 of $5.10–$5.70 both affirmed — but management’s tone has shifted from confident to highly assertive on Texas capital deployment, with a promised Q2 update on ~$9B of incremental opportunities that represents the key catalyst for the print.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 7, 2026) | Revised Guidance | Current Consensus | Note |
FY2026 Adjusted EPS | $4.80 – $5.30 | — | $5.14 | Guidance unchanged; consensus sits near midpoint ($5.05). No post-earnings revision event. |
FY2027 Adjusted EPS | $5.10 – $5.70 | — | $5.55 | Guidance unchanged; consensus near midpoint ($5.40). Affirmed on Q1 call. |
Long-Term EPS Growth Rate | 7% – 9% annually | — | N/A (not a consensus item) | Affirmed on Q1 call; described as “one of the highest in the utility sector.” |
FY2026 Total T&D CapEx | ~$13B (mgmt target) | — | $9.43B (VA consensus) | Mgmt target of $13B includes Oncor equity earnings; VA consensus may reflect Sempra-only CapEx. No formal revision. |
Oncor Base Rate Case (ROE / Equity Layer) | Final PUC approval received April 2026: ROE 9.75%, equity layer 43.5%, cost of debt 4.94% | — | N/A | ↑ Positive regulatory outcome; financial impact primarily in Q2 2026. Surcharge for Jan 1 – Jun 1, 2026 period to be recovered over remainder of year. |
Oncor UTM Filing | Inaugural filing submitted (April 2026); covers $4.4B of T&D assets placed in service since Jan 1, 2025 | — | N/A | Final order and updated rates expected H2 2026; interim rates possible ~Oct 4 if no order sooner. Hearing scheduled Aug 20. |
SIP/KKR Transaction Close | Q2 or Q3 2026 (FERC and antitrust approvals received) | — | N/A | Remaining items: Cameron partner consents and Japanese ECA consents. Close triggers CFO transition (Justin Bird replaces Karen Sedgwick). Rating agency threshold improvements expected ~6 months post-close. |
Incremental Capital Opportunities (~$9B) | ~$9B of incremental CapEx beyond base plan identified; update promised on Q2 call | — | N/A | Management referred to this as “incremental to the incremental” (I-squared). ERCOT released ~$2.9B South Dallas projects as part of this bucket. Q2 call is the expected update venue. |
SDG&E / SoCalGas 2028 GRC Filing | Filed June 15, 2026; SDG&E requesting $3.76B test year 2028 revenue; SoCalGas requesting $5.10B | — | N/A | New development post-Q1 call. CPUC decision expected by end of 2027; new rates effective Jan 2028. Attrition adjustments of 5.5–8.7% annually through 2031. |
Sources: Sempra Q1 2026 Earnings Call transcript (May 7, 2026); 8-K filed June 16, 2026 (SDG&E/SoCalGas 2028 GRC); 8-K filed July 9, 2026 (CFO appointment); Visible Alpha Consensus Data.
Key Takeaway: Estimates have been essentially flat since the Q1 print — FY2026 consensus EPS moved only −0.5% and FY2027 moved −0.3% — suggesting the street is in a holding pattern ahead of the Q2 call’s promised capital update; the gap between consensus and the guidance midpoint is narrow, leaving little cushion if management disappoints on the incremental plan.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of May 12, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 2026 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $1.086 | $1.064 | −2.0% | No Q-level guidance | No Q-level guidance | — | N/A |
Adj. EPS — FY2026 | $5.165 | $5.137 | −0.5% | $4.80 – $5.30 (mid: $5.05) | $4.80 – $5.30 (unchanged) | 0% | +1.6% above midpoint |
Adj. EPS — FY2027 | $5.571 | $5.547 | −0.4% | $5.10 – $5.70 (mid: $5.40) | $5.10 – $5.70 (unchanged) | 0% | +2.7% above midpoint |
Total Revenue — Q2 2026 | $3.157B | $3.186B | +0.9% | No guidance | No guidance | — | N/A |
Total Revenue — FY2026 | $13.878B | $13.854B | −0.2% | No guidance | No guidance | — | N/A |
The near-zero estimate drift since the Q1 print reflects a market in wait-and-see mode: analysts are holding models flat pending the Q2 call’s promised update on the ~$9B incremental capital bucket and SIP close timing. FY2026 consensus of $5.14 sits 1.6% above the guidance midpoint, providing a thin cushion — any downward revision to the incremental plan or SIP delay could push consensus below the midpoint and pressure the stock.
Source: Visible Alpha Consensus and Actuals Data (EPS - Diluted - Operating, Total revenues); as-of date May 12, 2026 used as post-Q1 baseline.
Key Takeaway: SRE has underperformed XLU by ~3 percentage points since the Q1 print (−5.4% vs. −2.2%), with the gap widening in late July as broader utility sector weakness and pre-earnings caution weighed; the underperformance is sentiment-driven rather than estimate-driven, creating a setup where a constructive Q2 call could close the gap quickly.
SRE vs. XLU (Utilities ETF) — Indexed to 100 at Q1 2026 Earnings Date (May 7, 2026). Source: Stock Price Data (Yahoo Finance).
SRE opened the post-Q1 period roughly in line with XLU, briefly outperforming in mid-June as the Oncor rate case approval and SDG&E/SoCalGas GRC filing provided positive regulatory catalysts. The stock peaked near $95 in early July before reversing sharply, with the underperformance accelerating in late July as peers reported Q2 results and the market rotated away from higher-beta utility names. The stock entered the Q2 print at ~$86.65 (Aug 4 close), down 5.4% from the Q1 earnings date, versus XLU down 2.2% — a 3.2 pp gap that appears driven by sentiment and sector rotation rather than any fundamental deterioration. No analyst rating changes were identified in the period. The SIP/KKR close (expected Q3 2026) and the incremental capital update are the two catalysts most likely to re-rate the stock.
Sector ETF used: XLU (Utilities Select Sector SPDR Fund) — appropriate for SRE’s diversified electric and gas utility profile. Source: Stock Price Data (Yahoo Finance).
Key Takeaway: The most important development since Q1 earnings is the CFO transition tied to the SIP/KKR close — a signal that the transaction is imminent — followed by the SDG&E/SoCalGas 2028 GRC filing, which sets the California regulatory agenda for the next two years; together these events reinforce the pure-play utility transformation thesis heading into the print.
Key Takeaway: Utility peers reporting Q2 2026 results universally confirmed accelerating data center and large load demand, constructive regulatory outcomes, and rising capital plan ambitions — all direct read-throughs for Sempra’s Texas (Oncor) and California utility businesses; the ERCOT-specific commentary from Xcel and the broader Texas load growth narrative from peers provide strong sector tailwinds heading into SRE’s print.
Note: All peer commentaries below are from Q2 2026 earnings calls (reporting the current quarter), ensuring relevance as forward read-throughs for SRE’s Q2 2026 print. The Entergy Investor Day (June 9, 2026) is also included as a post-Q1 event with material forward-looking content.
Read-Through Relevance: HIGH — NEE is the largest U.S. utility and a direct benchmark for regulated utility growth, large load demand, and regulatory frameworks.
Read-Through Relevance: MODERATE — EXC is a pure-play regulated utility with significant transmission exposure; its commentary on data center demand quality and PJM capacity dynamics is relevant to the broader utility investment thesis.
Read-Through Relevance: HIGH — XEL operates SPS in Texas/New Mexico (Permian Basin), making it the most direct ERCOT-adjacent peer for Oncor’s Texas load growth narrative.
Read-Through Relevance: HIGH — ETR is the highest-growth utility in the sector with the most aggressive data center/AI infrastructure exposure; its commentary on hyperscaler demand, capital plan expansion, and regulatory frameworks is a leading indicator for the sector.
Read-Through Relevance: MODERATE — D’s Virginia data center market is the world’s largest; its commentary on demand durability, large load frameworks, and the pending NEE merger provides sector context.
Read-Through Relevance: MODERATE — WEC’s data center tariff framework and capital plan execution provide a template for how regulated utilities are managing large load growth.
Read-Through Relevance: MODERATE — DUK is the largest regulated utility by rate base; its commentary on capital plan upside, regulatory settlements, and data center ESA conversion is a sector bellwether.
Peer | Event Date | Key SRE Read-Through Theme | Signal Direction |
NEE | Jul 24, 2026 | Large load demand accelerating; $2B/GW capital intensity; Texas gas pipeline advancing | Positive |
EXC | Jul 30, 2026 | ERCOT reliability outperformed PJM; data center demand quality improving with collateral; $12–17B transmission upside | Positive |
XEL | Jul 30, 2026 | Texas/Permian load growth confirmed; $5–6B/GW capital intensity; $10B+ incremental plan; Q2 EPS beat +24% YoY | Positive |
ETR | Jul 29, 2026 / Jun 9, 2026 | Hyperscale demand massive (Meta 5 GW / $50B); capital plan doubled to $67B; 16% rate base CAGR; Texas LNG demand | Positive |
D | Jul 31, 2026 | 53 GW data center pipeline; +11% contracted capacity since year-end; FFO/debt >15%; guidance reaffirmed | Positive |
WEC | Jul 29, 2026 | VLC tariff framework robust; concrete hyperscaler commitments; Q2 EPS beat; 7–8% LT growth reaffirmed | Positive |
DUK | Aug 4, 2026 | $5–10B capital upside identified; 7.8 GW ESAs signed; NC rate case settled at 9.8% ROE; guidance reaffirmed | Positive |
Overall peer read-through is uniformly positive for SRE’s Q2 print: every peer confirmed accelerating large load demand, constructive regulatory outcomes, and rising capital plan ambitions. The most actionable read-through is DUK’s $5–10B capital upside announcement (Aug 4), which demonstrates that the market rewards utilities that quantify incremental capital — directly relevant to SRE’s promised ~$9B update on the Q2 call.
Key Takeaway: No open-market buys or discretionary sells by executives since the Q1 print — all transactions are routine director compensation awards (phantom shares) or a single 10b5-1 planned sale; the absence of discretionary insider selling ahead of the Q2 print is a mild positive signal.
Open-market buys and sells only (Form 4 codes P/S) plus 10b5-1 plan activity. Routine director compensation awards (code A) and tax withholding (code F) are excluded from the signal table below.
Name | Title | Transaction Type | Shares | Date | Note |
Winn, Caroline Ann | Executive Vice President | Open Market Sale | 8,000 shares | Jun 17, 2026 | Discretionary sale (no 10b5-1 plan indicated). Winn is EVP of Sempra overseeing California utilities. Sold at ~$90–$91 range. Modest size relative to her remaining ~25,164 shares. |
Ferrero, Pablo | Director | Open Market Sale | 2,600 shares | May 18, 2026 | Discretionary sale (no 10b5-1 plan indicated). Small size; routine director liquidity. Sold ~11 days after Q1 earnings. |
Day, Diana L. | Chief Legal Counsel | 10b5-1 Planned Sale | 3,300 shares | May 14, 2026 | Pre-planned 10b5-1 sale (overall_10b5 = True). Obligation-driven; not a discretionary signal. Sold 7 days after Q1 earnings. |
All other Form 4 filings in the period (May 12–July 2, 2026) are director compensation awards (transaction code A) of phantom shares or common stock — routine annual equity grants, not open-market transactions. No open-market buys were filed by any insider since the Q1 print. The two discretionary sales (Winn 8,000 shares; Ferrero 2,600 shares) are small relative to each insider’s remaining holdings and do not constitute a meaningful negative signal. The 10b5-1 sale by Chief Legal Counsel Day is obligation-driven and should be disregarded for signal purposes.
Source: Insider Transaction Data (SEC Form 4 filings via Financial Modeling Prep).